Date	Name	Title	Type	Shares Traded	Price Range
Apr 18, 2011	patterson matthew r	Officer	Acquisition (Non Open Market)	50,000	n/a
Aug 14, 2008	weinhoff gregory m	Director	Sell	50,000	17.00
Jun 27, 2007	topper james n	Director	Buy	52,788	10.95 - 11.23
Jun 27, 2007	topper james n	Director	Buy	91,612	11.11 - 11.50
Jun 5, 2007	Chl Medical Partners ii side fund, L.p.	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	124,683	n/a
Jun 5, 2007	Chl Medical Partners ii, L.p.	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	124,683	n/a
Jun 5, 2007	garden state life sciences venture fund l p	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	354,940	n/a
Jun 5, 2007	quaker bio ventures lp	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	354,940	n/a
Mar 7, 2012	barrett m james	Director	Buy	925,154	5.70
Mar 7, 2012	new enterprise associates 11 lp	Beneficial Owner (10% or more)	Buy	925,154	5.70
Jun 5, 2007	garden state life sciences venture fund l p	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	1,064,822	n/a
Jun 5, 2007	quaker bio ventures lp	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	1,064,822	n/a
Mar 7, 2012	barris peter j	Beneficial Owner (10% or more)	Buy	1,140,000	5.70
Mar 7, 2012	kramlich c richard	Beneficial Owner (10% or more)	Buy	1,140,000	5.70
Mar 7, 2012	newhall charles w iii	Beneficial Owner (10% or more)	Buy	1,140,000	5.70
Mar 7, 2012	perry mark w	Beneficial Owner (10% or more)	Buy	1,140,000	5.70
Jun 5, 2007	neff p sherrill	Director	Acquisition (Non Open Market)	1,419,762	n/a
Jun 5, 2007	Chl Medical Partners ii side fund, L.p.	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	1,850,540	n/a
Jun 5, 2007	Chl Medical Partners ii, L.p.	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	1,850,540	n/a
Jun 5, 2007	weinhoff gregory m	Director	Acquisition (Non Open Market)	1,975,223	n/a
Showing 361-380 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.